Home>Topics>Companies>Abbott Laboratories

Abbott Laboratories ABT

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Abbott Earnings Preview: Emerging Markets And New Products Likely To Drive Sales

      Headlines

      Wed, 16 Apr 2014

      By Trefis : Abbott Labs ( ABT ) is scheduled to release its Q1 2014 earnings on Wednesday, April 16. In the previous quarter, operational sales increased

    2. Abbott's Weak Revenue Growth in First Quarter Should Improve as Year Unfolds

      Commentary

      Wed, 16 Apr 2014

      Abbott Laboratories posted first-quarter results that fell short of our expectations on the top line, but made up for it on the bottom line. We

    3. Abbott's CEO Discusses Q1 2014 Results - Earnings Call Transcript

      Headlines

      Wed, 16 Apr 2014

      Abbott Laboratories ( ABT ) Q1 2014 Results Earnings Conference Call April 16, 2014 9:00 AM ET Executives Brian Yoor - Vice President, Investor Relations

    4. UPDATE 3- Abbott Laboratories profit beats forecast, but sales lag

      Headlines

      Wed, 16 Apr 2014

      (Adds analyst comments, details on products, updates trading)

    5. RPT-UPDATE 2-Abbott beats profit forecast, but sales lag

      Headlines

      Wed, 16 Apr 2014

      April 16 (Reuters) - Abbott Laboratories Inc reported better-than-expected quarterly earnings on cost controls, but sales came in slightly below Wall Street expectations.

    6. More color on Abbott's Q1 results

      Headlines

      Wed, 16 Apr 2014

      Overall operational sales for Q1 grew 0.5% for Abbott Laboratories ( ABT ) to ~$5.2B. Diagnostics and Medical Devices grew 5.1% and 0.3% , respectively, while Nutrition fell 1.7% and Pharmaceuticals

    7. Abbott Laboratories Discusses Q1 2014 Results (Webcast)

      Headlines

      Wed, 16 Apr 2014

      Complete Story »

    8. Abbott Laboratories beats by $0.05, misses on revenue

      Headlines

      Wed, 16 Apr 2014

      Abbott Laboratories ( ABT ): Q1 EPS of $0.41 beats by $0.05 . Revenue of $5.24B (-2.6% Y/Y) misses by $50M . Press Release Post your comment!

    9. Abbott Labs Is A Solid Stock For Any Dividend Growth Portfolio

      Headlines

      Wed, 16 Apr 2014

      By Abba's Aces: The last time I wrote about Abbott Laboratories ( ABT ) I stated, "Due to the bullish technicals ..... the 2.56% gain the S&P 500 ( SPY ) posted. Abbott Laboratories is engaged in the discovery, development, manufacture

    « Prev12345Next »
    Content Partners